Yves Agid médecin neurologue français
Agid, Yves
Agid, Yves 1940-....
Agid, Yves, 1940-...., neurologue
VIAF ID: 23804671 (Personal)
Permalink: http://viaf.org/viaf/23804671
Preferred Forms
- 200 _ | ‡a Agid ‡b Yves ‡f 1940-....
- 100 1 _ ‡a Agid, Yves
- 100 1 _ ‡a Agid, Yves
-
-
-
- 100 1 _ ‡a Agid, Yves
-
- 100 1 _ ‡a Agid, Yves ‡d 1940-
- 100 1 _ ‡a Agid, Yves ‡d 1940-
- 100 1 _ ‡a Agid, Yves, ‡d 1940-...., ‡c neurologue
- 100 0 _ ‡a Yves Agid ‡c médecin neurologue français
4xx's: Alternate Name Forms (12)
Works
Title | Sources |
---|---|
Atypical Parkinsonian disorders : clinical and research aspects | |
Automatisation of histological quantification by image analysis : application to the study of neuron's death mecanism in Parkinson's disease. | |
cellules gliales | |
Le cerveau et les maux de la parole : aphasie, dyslexie, surdité, bégaiement... | |
cerveau, machine à inventer | |
cerveau rebranché | |
Chimie et cerveau | |
Cholinergic systems in human brain: physiopathological study in alzheimer's disease. | |
Comprendre le monde : les grands entretiens de la "Revue XXI. | |
Current Trends in the Treatment of Parkinson's Disease | |
Etude des mécanismes du contrôle de l’équilibre au cours de l’initiation de la marche chez l’homme | |
ETUDE DES SYSTEMES CHOLINERGIQUES CHEZ L'HOMME : IMPLICATIONS PHYSIOPATHOLOGIQUES DANS LA MALADIE D'ALZHEIMER | |
FUNCTIONAL AND NEURONAL MECHANISMS IN HUMANS/BASAL GANGLIA AND CEREBELLUM. | |
Glial man : a revolution in neuroscience | |
Intracerebral grafts of dopaminergic neurons : behavioral effects, physiology and development. | |
Je m'amuse à vieillir : le cerveau, maître du temps | |
Je marche donc je pense | |
Levodopa. Is toxicity a myth? 1998. | |
L'homme glial: Une révolution dans les sciences du cerveau | |
L'homme subconscient : le cerveau et ses erreurs | |
L'impact des neurosciences sur les thérapies | |
Maladie d’Alzheimer : épistémologie, éthique, innovation. | |
MECANISMES FONCTIONNELS ET NEURONAUX DES REGULATIONS TEMPORELLES CHEZ L'HOMME : NOYAUX GRIS CENTRAUX ET CERVELET | |
Mechanisms of balance control during human gait initiation. | |
Médecine expérimentale passé, présent, avenir | |
Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains | |
MISE AU POINT ET VALIDATION D'UNE EPREUVE DE REACTIONS DIFFEREES : APPLICATION A DES PATIENTS ATTEINTS D'AFFECTIONS DEGENERATIVES SOUS-CORTICALES ; APPLICATION A DES PATIENTS SCHIZOPHRENES | |
LA MONOAMINE OXYDASE-B JOUE-T-ELLE UN ROLE DANS LA MORT NEURONALE AU COURS DE LA MALADIE DE PARKINSON ? | |
La naissance du savoir : dans la tête des grands scientifiques | |
Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes | |
Pathology of symptomatic tremors. | |
Progressive supranuclear palsy, 1992: | |
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease | |
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain | |
Regional and cellular presenilin 2 (STM2) gene expression in the human brain | |
Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human Brain | |
Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects. | |
Restoration of normal motor control in Parkinson's disease during REM sleep | |
Retrograde axonal transport of125I-tetanus toxin as a too for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatum | |
Rôle du dysfonctionnement des noyaux gris centraux dans la genèse des troubles du comportement : à propos de la stimulation des structures cérébrales profondes dans diverses affections neuropsychiatriques | |
The role of basal ganglia dysfunction in the genesis of behavioural disorders : a study using deep brain stimulation in various neuropsychiatric diseases. | |
Saccade disturbances after bilateral lentiform nucleus lesions in humans | |
Savoirs, éthique et grand âge | |
Sequences of memory-guided saccades in Parkinson's disease. | |
Singing in the brain: a new form of complex partial seizure? | |
Soigner les dysfonctionnements | |
Somatostatin and dementia in Parkinson's disease | |
Somatostatin receptors in brain and pituitary | |
Squalenoyl-Adenosine Nanoparticles and cerebral ischémia : characterization of the passage of the Blood-Brain Barrier, pharmacological efficacy and theranostic. | |
Stimulation bilatérale du noyau sous-thalamique : prédictibilité clinique et mécanismes neurophysiologiques dans la maladie de Parkinson | |
Striatal dopamine deficiency in Parkinson's disease: role of aging | |
Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study | |
Subconsciousness : automatic behavior and the brain | |
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease | |
Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits | |
Subthalamic nucleus stimulation : clinical predictive factors and neurophysiological mechanisms in Parkinson's disease. | |
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder | |
Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons | |
LE SYSTEME NIGROSTRIE DOPAMINERGIQUE CHEZ LE RAT. METABOLISME DE LA DOPAMINE STRIATALE APRES LESION SELECTIVE DES NEURONES DOPAMINERGIQUES PAR INJECTION INTRATISSULAIRE DE 6-HYDROXYDOPAMINE. INTERACTIONS AVEC LES SYSTEMES CHOLINERGIQUES | |
Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia | |
Temporal limits of spatial working memory in humans. | |
Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease | |
Titres et travaux | |
Tourette syndrome deep brain stimulation: a review and updated recommendations | |
Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains | |
À travers les âges de la vie | |
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration | |
Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease | |
trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study | |
Tyrosine hydroxylase gene expression in human ventral mesencephalon: detection of tyrosine hydroxylase messenger RNA in neurites | |
Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain | |
Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness | |
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis | |
Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study | |
[درک نحوه عملکرد و اختلالات مغز]. | |
ਮਨੁੱਖੀ ਦਿਮਾਗ ਵਿੱਚ ਡੋਪਾਮਾਈਨ ਅਤੇ ਮੈਥੀਓਨਾਈਨ-ਐਨਕੇਫਾਲਿਨ |